C
Céline Guidoux
Researcher at University of Paris
Publications - 32
Citations - 2525
Céline Guidoux is an academic researcher from University of Paris. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 20, co-authored 31 publications receiving 1970 citations. Previous affiliations of Céline Guidoux include French Institute of Health and Medical Research & Paris Diderot University.
Papers
More filters
Journal ArticleDOI
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Jean-Louis Mas,Genevieve A. Derumeaux,Benoit Guillon,Evelyne Massardier,Hassan Hosseini,Laura Mechtouff,Caroline Arquizan,Yannick Béjot,Fabrice Vuillier,Olivier Detante,Céline Guidoux,Sandrine Canaple,Claudia Vaduva,Nelly Dequatre-Ponchelle,Igor Sibon,Pierre Garnier,Anna Ferrier,Serge Timsit,Emmanuelle Robinet-Borgomano,Denis Sablot,Jean-Christophe Lacour,Mathieu Zuber,Pascal Favrole,Jean-François Pinel,Marion Apoil,Peggy Reiner,Catherine Lefebvre,Patrice Guerin,Christophe Piot,Roland Rossi,Jean-Luc Dubois-Randé,Jean-Christophe Eicher,Nicolas Meneveau,Jean-René Lusson,Bernard Bertrand,Jean-Marc Schleich,François Godart,Jean-Benoit Thambo,Laurent Leborgne,Patrik Michel,Luc Pierard,Guillaume Turc,Martine Barthelet,Anaïs Charles-Nelson,Christian Weimar,Thierry Moulin,Jean-Michel Juliard,Gilles Chatellier +47 more
TL;DR: Among patients who had had a recent cryptogenic stroke attributed to PFO with an associated atrial septal aneurysm or large interatrial shunt, the rate of stroke recurrence was lower among those assigned to P FO closure combined with antiplatelet therapy than among those assign to anti platelet therapy alone.
Journal ArticleDOI
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
Pierre Amarenco,Jae-Hyung Kim,J. Labreuche,Hugo Charles,Jérémie Abtan,Yannick Béjot,Lucie Cabrejo,Cha Jk,Gregory Ducrocq,M Giroud,Céline Guidoux,Hobeanu C,Kim Yj,Bertrand Lapergue,Philippa C. Lavallée,Lee Bc,Lee Kb,Leys D,Mahagne Mh,Elena Meseguer,Nighoghossian N,Fernando Pico,Yves Samson,Igor Sibon,Phillippe Gabriel Steg,Sung Sm,Pierre-Jean Touboul,Emmanuel Touzé,Olivier Varenne,Eric Vicaut,Yelles N,Eric Bruckert +31 more
TL;DR: After an ischemic stroke or TIA with evidence of atherosclerosis, patients who had a target LDL cholesterol level of less than 70 mg per deciliter had a lower risk of subsequent cardiovascular events than those whoHad a target range of 90 mg to 110 mg perDeciliter.
Journal ArticleDOI
Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study
Mikael Mazighi,Jean Michel Serfaty,Julien Labreuche,Jean Pierre Laissy,Elena Meseguer,Philippa C. Lavallée,Lucie Cabrejo,Tarik Slaoui,Céline Guidoux,Bertrand Lapergue,Isabelle F. Klein,Jean-Marc Olivot,Gai Raphaeli,Christiane Gohin,Elisabeth Schouman Claeys,Pierre Amarenco +15 more
TL;DR: An IV-endovascular approach is associated with higher recanalisation rates than is IV alteplase in patients with stroke and confirmed arterial occlusion and a shorter time from symptom onset to recanAlisation isassociated with better clinical outcomes.
Journal ArticleDOI
Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis: A Registry and Systematic Review
Jean-Philippe Desilles,Elena Meseguer,Julien Labreuche,Bertrand Lapergue,Gaia Sirimarco,Jaime Gonzalez-Valcarcel,Philippa C. Lavallée,Lucie Cabrejo,Céline Guidoux,Isabelle F. Klein,Pierre Amarenco,Mikael Mazighi +11 more
TL;DR: It is confirmed that AGL and history of diabetes mellitus are associated with poor clinical outcome after thrombolysis and AGL may be a surrogate marker of brain infarction severity rather than a causal factor.
Journal ArticleDOI
Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction
Pierre Amarenco,Philippa C. Lavallée,Julien Labreuche,Gregory Ducrocq,Jean-Michel Juliard,Laurent J. Feldman,Lucie Cabrejo,Elena Meseguer,Céline Guidoux,Valérie Adraï,Samina Ratani,Jérôme Kusmierek,Bertrand Lapergue,Isabelle F. Klein,Fernando Góngora-Rivera,Arturo Jaramillo,Mikael Mazighi,Pierre-Jean Touboul,Philippe Gabriel Steg +18 more
TL;DR: There is a high burden of silent coronary artery disease in patients with nonfatal cerebral infarction and no known coronary heart disease, even in the absence of systemic atherosclerosis.